Quality-Adjusted Life Expectancy and Cost-Effectiveness Thresholds in Three High-Income Regions in Asia [0.03%]
亚洲三大高收入地区的质量调整生命年和成本效益阈值
Xinyu Zhao,Yawen Jiang
Xinyu Zhao
Background and objective: Cost-effectiveness thresholds (CETs) are essential for health technology assessments and resource allocation in healthcare. However, empirical CET estimates alongside quality-adjusted life expect...
Lost in Translation? A Scoping Review to Explore the Translation and Cultural Adaptation of Preference-Based Measures of Quality of Life [0.03%]
迷失在翻译中？一项范围性综述探索基于偏好的生命质量测量工具的翻译及文化改编问题
Jenny Cleland,Kiri Lay,Julie Ratcliffe et al.
Jenny Cleland et al.
Background: Preference-based measures (PBMs) of quality of life are an important tool to inform the evaluation of health and social care interventions and services. Traditionally, PBMs have tended to be developed in a sin...
Towards Environmentally Extended Health Economic Analysis Plans: A Case Study for the MEL-SELF Trial [0.03%]
基于MEL-SELF试验的环境扩展卫生经济分析计划研究
Jake T W Williams,Katy J L Bell,Scott McAlister et al.
Jake T W Williams et al.
Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in Sweden [0.03%]
瑞典药品报销中的定性和定量评估的一致性：严重程度的证据
Martin Henriksson,Lars Sandman,Jonathan Siverskog
Martin Henriksson
Background and objectives: Publicly funded healthcare systems that consider a trade-off between efficiency and equity by allowing a higher cost per patient benefit in patients with more severe conditions must somehow asse...
The Economic Value of Non-pharmaceutical Interventions for Influenza and COVID-19: A Systematic Review [0.03%]
流感和冠状病毒非药物干预的经济价值：系统性综述
Hui Yee Yeo,Trinh Manh Hung,Nhung Nghiem et al.
Hui Yee Yeo et al.
Background: Non-pharmaceutical interventions (NPIs) are central to mitigating COVID-19 and influenza, yet comparative economic evaluations remain scarce. This systematic review assessed the cost effectiveness and reportin...
A Systematic Review of Microsimulation Models in Cardiometabolic Disease: Model Calibration and Validation [0.03%]
心血管疾病中微模拟模型的系统评价：模型校准和验证
Danwei Yang,Zhixin Cao,Jayoung Byun et al.
Danwei Yang et al.
Background: Microsimulation models are increasingly used to project health trajectories of individuals with cardiometabolic diseases, including type 2 diabetes, obesity, cardiovascular disease, and chronic kidney disease....
Insights from Patient and Public Involvement (PPI) in Economic Evaluations of Severe Mental Illness: Comparing Recovering Quality of Life (ReQoL) and the EQ-5D-5L [0.03%]
服务对象和公众参与严重精神疾病经济评价的体会——生活质量恢复量表(ReQoL)与EQ-5D-5L对照研究
Gemma Shields,Cheyann J Heap,Raj Hazzard et al.
Gemma Shields et al.
Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication [0.03%]
金融经济学视角下的医疗卫生投资评估：疾病清除和根除减少系统风险的价值分析举隅
Megha Rao,Mark Freeman,Jacco Thijssen et al.
Megha Rao et al.
System-level risks generate volatility that can threaten the stability of public health systems and jeopardise population health. In financial terms, these risks may be systematic, arising from macroeconomic shocks, or systemic, arising fro...
The Increasing Value of Environmental Sustainability Assessments in Healthcare Policy and Technology Evaluation [0.03%]
环境可持续性评估在医疗卫生政策和技术评价中的价值日益增加
Lindsay Nicholson,Nick Pooley,Gregor Skeldon et al.
Lindsay Nicholson et al.
Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France [0.03%]
法国新生儿脊髓性肌萎缩症筛查的成本效益及公共卫生影响
Sebastien Eymere,Oyin Opeifa,Aurélie Meunier et al.
Sebastien Eymere et al.
Aims: Spinal muscular atrophy (SMA) was recently included in the French national newborn screening (NBS) program. The aim of this study was to assess the public health impact and cost-utility of SMA NBS in the French sett...